DK0439442T3 - Faktor X-LACI-hybridprotein - Google Patents

Faktor X-LACI-hybridprotein

Info

Publication number
DK0439442T3
DK0439442T3 DK91870008.9T DK91870008T DK0439442T3 DK 0439442 T3 DK0439442 T3 DK 0439442T3 DK 91870008 T DK91870008 T DK 91870008T DK 0439442 T3 DK0439442 T3 DK 0439442T3
Authority
DK
Denmark
Prior art keywords
laci
factor
hybrid protein
amino acid
acid sequence
Prior art date
Application number
DK91870008.9T
Other languages
Danish (da)
English (en)
Inventor
Thomas James Girard
George John Broze Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0439442T3 publication Critical patent/DK0439442T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91870008.9T 1990-01-25 1991-01-21 Faktor X-LACI-hybridprotein DK0439442T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47028990A 1990-01-25 1990-01-25

Publications (1)

Publication Number Publication Date
DK0439442T3 true DK0439442T3 (da) 1996-07-08

Family

ID=23866994

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91870008.9T DK0439442T3 (da) 1990-01-25 1991-01-21 Faktor X-LACI-hybridprotein

Country Status (8)

Country Link
EP (1) EP0439442B1 (fr)
JP (1) JP2560150B2 (fr)
AT (1) ATE135044T1 (fr)
CA (1) CA2034881C (fr)
DE (1) DE69117545T2 (fr)
DK (1) DK0439442T3 (fr)
ES (1) ES2086521T3 (fr)
GR (1) GR3019877T3 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135585T1 (de) * 1990-08-27 1996-04-15 Monsanto Co Anticoagulatorische zusammensetzung aus laci und sulfatierten polysacchariden
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
EP0671944A4 (fr) * 1992-09-25 1996-07-24 Corvas Int Inc Inhibiteurs de complexe facteur viia-thromboplastine tissulaire derives d'un inhibiteur de trypsine pancreatique de bovin.
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
CA2202351A1 (fr) * 1994-10-18 1996-04-25 George Phillip Vlasuk Proteines anticoagulantes et inhibiteurs de la serine-protease extraits de nematodes
JP3811186B2 (ja) 1994-10-18 2006-08-16 コーバス インターナショナル， インコーポレイテッド 線虫から抽出されるセリンプロテアーゼ阻害剤および抗凝固性タンパク質
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
ATE234359T1 (de) * 1995-12-01 2003-03-15 Genentech Inc Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
HU226419B1 (en) 1996-03-11 2008-12-29 Aerovance Human bikunin
EP0927764B1 (fr) * 1997-12-03 2004-05-26 Boehringer Mannheim Gmbh Serine protéases chimériques
US6159722A (en) 1997-12-03 2000-12-12 Boehringer Mannheim Gmbh Chimeric serine proteases
JP2003530838A (ja) * 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor

Also Published As

Publication number Publication date
CA2034881C (fr) 2001-05-29
EP0439442B1 (fr) 1996-03-06
ES2086521T3 (es) 1996-07-01
DE69117545D1 (de) 1996-04-11
EP0439442A2 (fr) 1991-07-31
ATE135044T1 (de) 1996-03-15
EP0439442A3 (en) 1992-05-27
JP2560150B2 (ja) 1996-12-04
CA2034881A1 (fr) 1991-07-26
GR3019877T3 (en) 1996-08-31
JPH04211000A (ja) 1992-08-03
DE69117545T2 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
ATE135044T1 (de) Faktor x-laci-hybridprotein
ATE200783T1 (de) Neuartige peptidderivate
ES2031806T3 (es) Factor de permeabilidad vascular humano.
DE68923819T2 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE81503T1 (de) N-(mercaptoalkyl)-omega-hydroxyalkylamide und ihre verwendung als reduktionsmittel in einem verfahren zur bleibenden gestaltung von haaren.
FI883487A (fi) Ihmisen kudostekijäinhibiittorin DNA-klooni
DK0625912T3 (da) Behandling af inflammatorisk tarmsygdom
PT81990B (pt) Processo para a preparacao de derivados peptidicos inibidores da renina e das proteases acidas
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
FI925696A0 (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
ATE151996T1 (de) Kit zur einführung eines fremdkörpers, der geeignet zur identifikation eines tieres ist
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DK366380A (da) Anvendelsen af grp og salte deraf
DK53290A (da) Syntetiske gaer-leader-peptider
DK288581A (da) Anvendelse af peptider som diagnost ikum